You are here: Industry Insights > Pfizer

News List

BioNTech signs Covid-19 vaccine deals with Pfizer and Fosun pharmaceutical-technology
March 18, 2020
German biotechnology firm BioNTech has partnered with Pfizer to jointly develop and distribute a potential mRNA-based Covid-19 vaccine.
Pfizer, BioNTech to co-develop potential coronavirus vaccine expresspharma
March 18, 2020
US drugmaker Pfizer has signed a deal with Germany’s BioNTech to co-develop a potential vaccine for the coronavirus using BioNTech’s mRNA-based drug development platform.
Merck, Pfizer terminate Bavencio head and neck cancer trial pharmatimes
March 17, 2020
Merck KGaA and Pfizer have decided to stop their Phase III JAVELIN study testing Bavencio (avelumab) as a potential treatment for certain patients with advanced head and neck cancer.
Merck and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study prnasia
March 14, 2020
A detailed analysis of the Phase III JAVELIN Head and Neck 100 study is being conducted and study findings will be shared with the scientific community.
Pfizer identifies antiviral compounds with potential as coronavirus treatments expresspharma
March 04, 2020
The company hopes to start testing them by the end of the year if any of the compounds are successful.
Pfizer signs oncology agreement with STR-focused eFFECTOR pharmaceutical-technology
January 14, 2020
San Diego-based eFFECTOR has signed an exclusive worldwide license and collaboration agreement with Pfizer in the oncology field. The collaboration focuses on the development of small molecule inhibitors of eukaryotic initiation factor 4E (elF4E) ...
GSK consolidates Pfizer consumer brands under Publicis unit fiercepharma
January 06, 2020
GlaxoSmithKline has awarded Publicis Media and its bespoke platformGSK more business, adding the former Pfizer Consumer Healthcare brands to its portfolio.
Theravance Biopharma and Pfizer Inc. enter global license agreement for skin-targeted, locally-acting pan-Janus kinase (JAK) inhibitor program worldpharmanews
December 24, 2019
Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. and Pfizer Inc. announced that the companies have entered into a global license agreement for ...
Sangamo Announces Early Completion of Transfer to Pfizer of SB-525 americanpharmaceuticalreview
December 24, 2019
Sangamo Therapeutics announced the completion of the transfer to Pfizer of the SB-525 Hemophilia A gene therapy Investigational New Drug application (IND).
Sosei Heptares Announces Clinical Start of Drug Discovery Collaboration with Pfizer americanpharmaceuticalreview
December 24, 2019
Sosei Group has been notified by its strategic alliance partner Pfizer that it has dosed the first subject in a clinical trial with a new drug candidate nominated from the multi-target drug ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page